799 related articles for article (PubMed ID: 25362209)
1. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
[TBL] [Abstract][Full Text] [Related]
2. CTRP9 knockout exaggerates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy through inhibiting the LKB1/AMPK pathway.
Zuo A; Zhao X; Li T; Li J; Lei S; Chen J; Xu D; Song C; Liu T; Li C; Guo Y
J Cell Mol Med; 2020 Feb; 24(4):2635-2647. PubMed ID: 31930700
[TBL] [Abstract][Full Text] [Related]
3. Deletion of protein tyrosine phosphatase 1B rescues against myocardial anomalies in high fat diet-induced obesity: Role of AMPK-dependent autophagy.
Kandadi MR; Panzhinskiy E; Roe ND; Nair S; Hu D; Sun A
Biochim Biophys Acta; 2015 Feb; 1852(2):299-309. PubMed ID: 25018087
[TBL] [Abstract][Full Text] [Related]
4. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
[TBL] [Abstract][Full Text] [Related]
5. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
[TBL] [Abstract][Full Text] [Related]
6. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways.
Kang S; Chemaly ER; Hajjar RJ; Lebeche D
J Biol Chem; 2011 May; 286(21):18465-73. PubMed ID: 21478152
[TBL] [Abstract][Full Text] [Related]
7. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.
Ganesan J; Ramanujam D; Sassi Y; Ahles A; Jentzsch C; Werfel S; Leierseder S; Loyer X; Giacca M; Zentilin L; Thum T; Laggerbauer B; Engelhardt S
Circulation; 2013 May; 127(21):2097-106. PubMed ID: 23625957
[TBL] [Abstract][Full Text] [Related]
8. Mst1 knockdown alleviates cardiac lipotoxicity and inhibits the development of diabetic cardiomyopathy in db/db mice.
Xiong Z; Li Y; Zhao Z; Zhang Y; Man W; Lin J; Dong Y; Liu L; Wang B; Wang H; Guo B; Li C; Li F; Wang H; Sun D
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165806. PubMed ID: 32320827
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice.
Noda K; Nakajima S; Godo S; Saito H; Ikeda S; Shimizu T; Enkhjargal B; Fukumoto Y; Tsukita S; Yamada T; Katagiri H; Shimokawa H
PLoS One; 2014; 9(11):e110446. PubMed ID: 25365359
[TBL] [Abstract][Full Text] [Related]
13. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Expression Signature Is Altered in the Cardiac Remodeling Induced by High Fat Diets.
Guedes EC; França GS; Lino CA; Koyama FC; Moreira Ldo N; Alexandre JG; Barreto-Chaves ML; Galante PA; Diniz GP
J Cell Physiol; 2016 Aug; 231(8):1771-83. PubMed ID: 26638879
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-297 promotes cardiomyocyte hypertrophy via targeting sigma-1 receptor.
Bao Q; Zhao M; Chen L; Wang Y; Wu S; Wu W; Liu X
Life Sci; 2017 Apr; 175():1-10. PubMed ID: 28286226
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.
Dolinsky VW; Chan AY; Robillard Frayne I; Light PE; Des Rosiers C; Dyck JR
Circulation; 2009 Mar; 119(12):1643-52. PubMed ID: 19289642
[TBL] [Abstract][Full Text] [Related]
18. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin Upregulates MiR-133a in Cardiac Hypertrophy through AMPK Activation and Reduced ERK1/2 Phosphorylation.
Li Y; Cai X; Guan Y; Wang L; Wang S; Li Y; Fu Y; Gao X; Su G
PLoS One; 2016; 11(2):e0148482. PubMed ID: 26845040
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
